“A NOVEL FORMULATION DESIGN FOR EXTENDED RELEASE TABLET OF ETODOLAC FOR THE TREATMENT OF RHEUMATOID ARTHRITIS”, Journal of Pharmaceutical Negative Results, pp. 972–979, Sep. 2022, doi: 10.47750/pnr.2022.13.S01.116.